In Brief: McNeil plant reinspection
This article was originally published in The Tan Sheet
Executive Summary
McNeil plant reinspection: J&J division's Las Piedras, Puerto Rico manufacturing facility is ready for reinspection by FDA, the J&J unit says. McNeil received a warning letter on Nov. 18 citing deviations from the Good Manufacturing Practice regs for Tylenol products. McNeil failed to conduct potency testing on all finished product lots and dissolution testing on film-coated or gelatin-coated tablets made before July 1, 1996, the letter says. The firm notes that it has provided FDA with all of the requested information documenting product testing...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning